Objectives: The aim of this prospective observational study was to evaluate the influence of OPRM1 polymorphism on the analgesic efficacy (including visual analog scale [VAS] scores and requirement for rescue analgesia) of a standard dose of intrathecal morphine.
I
ndividual differences in opioid consumption after surgery may be caused by various factors (sex, age, ethnicity, hepatic and renal function, emotional status) including genetic variability. [1] [2] [3] [4] [5] A single nucleotide polymorphism related to those genes involved in opioid pharmacodynamics and kinetics may lead to interindividual differences in response to these drugs. 6 Among the genes involved in opioid pharmacodynamics, the one encoding m-subtype receptor for opioids (OPRM1) has been investigated in a few studies. [7] [8] [9] [10] The differences between OPRM1 homozygous 118A and polymorphous 118G allele carriers on pain perception after intrathecal administration of morphine has been evaluated in some studies with different outcomes in Asian and North American populations. [11] [12] [13] Wong and colleagues found no differences in duration of analgesic effect, need of analgesic supplementation, or incidence of postoperative nausea and vomiting (PONV) between the 118A and the 118G groups; pruritus was found to be less common in the 118G group during the first 24 hours after intrathecal morphine administration. 11 Sia et al 12 found greater opioid consumption (ie, morphine, administered via patient controlled analgesia pump) in Asian women carrying the 118G polymorphism than in women carrying homozygous AA or heterozygous AG. Tan and colleagues conducted a multiple regression analysis on factors associated with morphine consumption in the postoperative period: visual analog scale (VAS) score, ethnic origin, and A118G polymorphism were found to be significantly associated with opioid consumption. After correction for genotype, ethnicity was still a relevant factor associated with morphine consumption, with Indian women having the highest VAS scores and requiring the highest dosages of analgesic medications. 13 To our knowledge, no one has evaluated the influence of OPRM1 polymorphism on pain perception after cesarean section conducted under spinal anesthesia and subarachnoid administration of morphine in the white Italian population.
The aim of this observational, prospective study was to demonstrate that white Italian women carrying the G variants of OPRM1 polymorphism and scheduled for elective cesarean section in a tertiary University Hospital Italian perceived a greater postoperative pain (measured by VAS and consumption of rescue doses) and have a higher incidence of the most common opioid-related side effects after a standard dose of intrathecal morphine.
MATERIALS AND METHODS
The study was conducted between April and August 2015 at the Obstetrics and Gynecology Department of Careggi University Hospital, Florence, Italy. The study was approved by the Local Ethical Board (protocol number: BIO 14.034).
We selected a cohort of patients using the following inclusion criteria: elective cesarean section performed with low transverse abdominal incision (Pfannestiel incision) and spinal anesthesia, age above 18 years, obtainment of written informed consent, anesthesiological risk class American Society of Anesthesiology I and II, singleton pregnancy, gestational age above 37 weeks, patient's (and her parents') white Italian origins. Patients in labor, allergic to local anesthetics, acetaminophen, or opioids, with a history of opioids and/or benzodiazepines abuse, contraindications to spinal anesthesia, or preexisting chronic pain syndromes were excluded.
The patients received a standardized spinal anesthesia at L2-L3 or L3-L4 level with administration of hyperbaric bupivacaine 12.5 mg and morphine 100 mcg. At the end of the surgery, acetaminophen 1 g IV was administered. For the first 48 hours in the postoperative period, the patients received acetaminophen 1 g IV q6hr. Pain levels were monitored with VAS pain scores incident pain (defined as VAS > 3) was treated with ketorolac 30 mg IV (not exceeding a total daily dose of 90 mg). Age, body weight (both before and at the end of pregnancy), height, body mass index, number of pregnancies, preceding surgery and cesarean sections, and educational level were obtained for all patients. Before discharge from the operating room and subsequently every 6 hours for the first 48 hours in the postoperative period, the following parameters were registered: vital parameters (SpO 2 , blood pressure, heart rate, and respiratory rate); VAS at rest (patient in bed, supine position) (the worst in the preceding 6 hours): VAS > 3 was considered a positive response; VAS during movements (pain elicited by a nursee while trying to lift a patient's head and shoulders from the bed): VAS > 3 was considered a positive response-any episodes of PONV (yes/no); any sensation of pruritus (yes/no); Ramsay sedation scale (1 = patient awake, 2 = patient sedated, easily awakened by verbal stimulus, 3 = moderate level of sedation, patient is not able to stay awake, 4 = patient deeply sedated, not awakened by verbal stimulus alone); rescue analgesic medications requirements (yes/no); antiemetic administration (yes/no); and any other side effect or complication following anesthetic technique or administration of IV analgesic medications. Blood was obtained from patients (5 mL in EDTA or citrate containing test tubes) before the initiation of surgery and conserved at À801C. Genomic DNA was isolated from venous whole blood using PureLink Genomic DNA kit (Invitrogen) and tested for DNA integrity by gel electrophoresis and purity by optical densitometry (260/280 nm). In total, 20 ng of DNA from samples was used for genotyping by Real-Time PCR using TaqMan SNP Genotyping Assays (Applied Biosystems) and TaqMan Genotyping Master mix (Applied Biosystems). This method discriminates from wild-type genotype AA and genotype with polymorphism AG or GG.
Statistical Analysis
We conducted an analysis of association between the risk of observing a high level of postoperative pain (and/or the incidence of side effects related with morphine administration, as secondary outcomes) and the presence of different polymorphisms of OPRM1 (or anthropometric and social parameters, as secondary outcomes).
To assess the difference in proportion of primary and secondary outcomes between genotype groups, the Fisher exact test was used. The proportion of difference in the confidence interval is also reported.
To identify primary outcome risk factors, logistic regression and the Fisher test, respectively, for continuous and dichotomous risk factor, were used.
Statistical significance was defined as P < 0.05.
RESULTS
In total, 63 parturients were enrolled during the study period. Their average age was 36.1 years ( ± 4.4); the average weight at the end of pregnancy was of 77.7 kg ( ± 13.4), whereas the weight average, measured before pregnancy, was of 66.5 kg ( ± 13.5); the average height was 164.9 cm ( ± 7.2); body mass index, calculated before pregnancy was 24.5 kg/m 2 ( ± 5.1). The 2 groups did not differ significantly with respect to age and anthropometric parameters (Table 1) .
A total of 45 patients (71%) were homozygous genotype A/A (118A group), 17 patients (27%) were heterozygous A/G, whereas genotype G/G was reported in 1 patient (2%). The patients carrying the G variants of OPRM1 were studied as 1 group (118G) because of the similar response in terms of pain and opioid-related side effects.
No significant differences in analgesic "rescue" doses' administration and/or in incidence of moderate/severe postoperative pain (VAS > 3) between the 2 groups were found. The lack of difference persisted both while analyzing the first 2 postoperative days separately and the first 48 There was also no significant difference in the incidence of PONV between the 2 groups (PONV in 48 h: PD = À0.08; CI, À0.35/0.2; P = NS. PONV in the first 24 h: PD = À 0.06; CI, À0.33/0.22; P = ÀNS. PONV after the first 24 h: PD = À 0.07; CI, À 0.34/0.21; P = NS.)
Pruritus was significantly more common in the 118A group than in the 118G group in the first 24 hours of the postoperative period (pruritus in 48 h: PD = À0.32; CI, À0.57/À 0.04; P = 0.01. Pruritus in the first 24 h: PD = Table 2) . None of the other analyzed risk factors was associated with a higher incidence of postoperative pain or any other of the observed outcomes (Tables 3, 4 ). There was also no significant difference in the other collected parameters between the 2 groups.
DISCUSSION
Several studies evaluated the correlation between the genotypic variants of OPRM1 receptor and intensity of pain in the postoperative period (both acute and chronic pain) with different results. 14 The same studies conducted in obstetric patients show conflicting results as well, particularly in the perception of postoperative pain after a cesarean section, both in epidural and in spinal anesthesia with intrathecal opioid administration.
Baber et al 15 recently reported that "significant differences in mean dose consumption were seen among the genotypic groups of the OPRM1 A118G." Patients carrying the "G" mutation needed higher doses of analgesic medications. Similar results were found in previous studies. 16, 17 Other studies did not find any correlation between different genotypes and postoperative pain intensity after cesarean section. 18 In an editorial, Wong 19 ascribed the contrasting results published in different papers to difficulties in interpretation of the data, genetic factors (the variants of OPRM1 are differently distributed depending on ethnic group), insufficient statistical power of the studies, genetic variability related to pain perception, and use of opioids as an endpoint of the studies.
Our study joins the cluster of such different studies with a few significant peculiarities.
First, our cohort has been accurately selected to include only women of Italian origins, allowing us to remove the confounding factor of ethnic differences; thereafter we evaluated for 48 hours, postoperatively, the effects of a single, standard dose of morphine administered intrathecally, using different classes of analgesic medications as rescue doses. Therefore, the response in terms of pain perception and side effects in the 2 groups of women has been evaluated both during the period of effect of intrathecal morphine (first 24 h) and during the succeeding 24 hours, without the overlapping effect of newly administered opioid doses.
Our study does not have enough empirical evidence to demonstrate that in Italian women undergoing elective cesarean section, the intensity of postoperative pain after intrathecal administration of morphine correlates with the genetic polymorphism. Other factors could play a major role in the perception of pain, such as previous experience and individual elaboration of painful sensations as well as other genetic-related components of the complex ways of pain perception and modulation.
The apparently fewer requests of analgesic rescue doses in the first 24 hours in the 118A group (a difference that did not reach statistical significance) is contradicted by the number of women reporting a VAS score >3 in the same period, which is similar in the 2 groups. This can reflect the patients' will of not taking any medication in the first period of lactation.
Instead, a significant difference was found in the perception of pruritus. A higher incidence of pruritus was observed in the 118A group during the period of peak action of morphine (first 24 h). The pathophysiology of opioid-related pruritus has not been completely clarified yet, but the connection between the action of the drug at its receptor and the development of the side effect is well established 20 ; naloxone is in fact one of the most effective treatments of opioid-induced pruritus. 21 Our study shows that in the Italian population there is a different incidence of pruritus in the postoperative period in response to intrathecal opioids related OPRM1 gene polymorphism, with a greater sensitivity in patients with the AA genotype.
Neither intensity of postoperative pain nor rescue doses of analgesic medications requirements appear to be significantly associated with OPRM1 polymorphism.
